| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.66B | 12.87B | 13.05B | 12.36B | 9.08B | 7.95B |
| Gross Profit | 9.10B | 8.40B | 7.72B | 7.91B | 7.54B | 7.88B |
| EBITDA | 3.03B | 3.62B | 3.41B | 3.45B | 3.53B | 3.87B |
| Net Income | 2.17B | 2.52B | 2.31B | 2.35B | 2.45B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 297.04B | 214.38B | 212.93B | 214.57B | 207.45B | 211.12B |
| Cash, Cash Equivalents and Short-Term Investments | 4.08B | 22.38B | 58.94B | 74.92B | 62.45B | 75.16B |
| Total Debt | 20.04B | 14.52B | 18.97B | 19.43B | 18.61B | 12.65B |
| Total Liabilities | 262.93B | 192.65B | 193.28B | 195.40B | 190.13B | 188.91B |
| Stockholders Equity | 34.11B | 21.72B | 19.64B | 19.17B | 17.33B | 22.21B |
Cash Flow | ||||||
| Free Cash Flow | 1.98B | 3.81B | 2.41B | 3.99B | 5.74B | 2.40B |
| Operating Cash Flow | 2.17B | 4.51B | 2.82B | 4.51B | 6.43B | 2.70B |
| Investing Cash Flow | 3.63B | -1.85B | 1.04B | -9.49B | -4.87B | -7.97B |
| Financing Cash Flow | -4.74B | -2.18B | -3.99B | 4.66B | -1.08B | 5.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $30.81B | 12.71 | 10.25% | 2.76% | -0.49% | 19.72% | |
73 Outperform | $26.57B | 12.33 | 7.63% | 2.89% | -0.44% | 34.70% | |
72 Outperform | $32.07B | 13.98 | 8.82% | 3.50% | 9.10% | 0.60% | |
72 Outperform | $23.49B | 10.08 | 11.78% | 3.74% | 2.53% | 16.52% | |
69 Neutral | $23.21B | 10.41 | 9.74% | 3.90% | 20.39% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $44.28B | 58.08 | 8.86% | 3.14% | 7.12% | -5.41% |